Monkeypox designated a notifiable disease
Legislation was laid on 7 June 2022 which made monkeypox a notifiable infectious disease under the Health Protection (Notification) Regulations 2010 from 8 June 2022. This means all doctors in England are required to notify their local council or local Health Protection Team (HPT) if they suspect a patient has monkeypox. Laboratories must also notify the UK Health Security Agency (UKHSA) if the monkeypox virus is identified in a laboratory sample.
Further details, including the latest updates on monkeypox, are available on the gov.uk website.
NHSE also have a monkeypox publication webpage
The Monkeypox workforce and training guidance as now been updated to reflect the:
- new batches of Monkeypox vaccine arriving in the UK • new legal mechanisms associated with each batch and
- intradermal route of injection.
The guidance is to support Workforce Leads and Lead Employers who are providing workforce to deliver immunisation for individuals at risk of exposure to Monkeypox.
|All Guidance including for Primary Care : The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
|UKHSA Letter: Immediate Actions in Response to Cases of monkeypox Virus in UK with no known travel history
|Recommendations for the use of pre and post exposure vaccination during a monkeypox incident
|Smallpox and monkeypox: the green book, chapter 29; information for public health professionals.
|Protecting you from monkeypox – information on the smallpox vaccination